Advanced in Primary Biliary Cholangitis

Dr. Matthew Cave

Hepatology
University Of Louisville Physicians Inc
401 E Chestnut St, Suite 310, 
Louisville, KY 
Advanced in Primary Biliary Cholangitis
University Of Louisville Physicians Inc
401 E Chestnut St, Suite 310, 
Louisville, KY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Matthew Cave is a Hepatologist in Louisville, Kentucky. Dr. Cave is rated as an Advanced provider by MediFind in the treatment of Primary Biliary Cholangitis. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Angiosarcoma of the Liver, Alcoholic Cirrhosis, Hepatitis, and Endoscopy.

His clinical research consists of co-authoring 85 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 1 clinical trial in the study of Primary Biliary Cholangitis.

Specialties
Hepatology
Licenses
Internal Medicine in KY
Hospital Affiliations
University Of Louisville Hospital
Baptist Health Lagrange
UOFL HEALTH - JEWISH HOSPITAL And Mary & Elizabeth Hospital
Baptist Health Hardin
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

UNIVERSITY OF LOUISVILLE PHYSICIANS INC
401 E Chestnut St, Suite 310, Louisville, KY 40202

Additional Areas of Focus

Dr. Cave has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
Enrollment Status: Terminated
Publish Date: March 09, 2023
Intervention Type: Drug
Study Drug: Obeticholic Acid 
Study Phase: Phase 4
A Proof-of-Concept and Dose-Ranging Study Investigating the Efficacy and Safety of HTD1801 in Adult Subjects With Primary Sclerosing Cholangitis (PSC)
A Proof-of-Concept and Dose-Ranging Study Investigating the Efficacy and Safety of HTD1801 in Adult Subjects With Primary Sclerosing Cholangitis (PSC)
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

85 Total Publications

Chronic and Heavy Drinking, Nutrition Status, and Progression of Liver Injury Negatively Affect the Mortality Risk in Patients Suffering from Alcohol-Associated Hepatitis.
Chronic and Heavy Drinking, Nutrition Status, and Progression of Liver Injury Negatively Affect the Mortality Risk in Patients Suffering from Alcohol-Associated Hepatitis.
Journal: Journal of clinical medicine
Published: June 27, 2025
Similar Doctors
Distinguished in Primary Biliary Cholangitis
Dr. Ashwani Singal
Hepatology
Distinguished in Primary Biliary Cholangitis
Dr. Ashwani Singal
Hepatology

University Of Louisville Physicians Inc

401 E Chestnut St, Suite 310, 
Louisville, KY 
 (0.1 miles away)
502-584-8563
Experience:
43+ years
Languages Spoken:
English
See accepted insurances

Ashwani Singal is a Hepatologist in Louisville, Kentucky. Dr. Singal has been practicing medicine for over 43 years and is rated as an Elite provider by MediFind in the treatment of Primary Biliary Cholangitis. His top areas of expertise are Alcoholic Cirrhosis, Hepatitis A, Hepatitis, Liver Transplant, and Gallbladder Removal.

Experienced in Primary Biliary Cholangitis
Dr. Luis Marsano
Hepatology
Experienced in Primary Biliary Cholangitis
Dr. Luis Marsano
Hepatology

University Of Louisville Physicians Inc

401 E Chestnut St, 
Louisville, KY 
 (0.1 miles away)
502-813-6410
Languages Spoken:
English
See accepted insurances

Luis Marsano is a Hepatologist in Louisville, Kentucky. Dr. Marsano is rated as a Distinguished provider by MediFind in the treatment of Primary Biliary Cholangitis. His top areas of expertise are Visceromegaly, Enlarged Liver, Cirrhosis, Endoscopy, and Colonoscopy.

Experienced in Primary Biliary Cholangitis
Dr. Craig Mcclain
Hepatology
Experienced in Primary Biliary Cholangitis
Dr. Craig Mcclain
Hepatology

University Of Louisville Physicians Inc

401 E Chestnut St, Suite 310, 
Louisville, KY 
 (0.1 miles away)
502-584-8563
Languages Spoken:
English
See accepted insurances

Craig Mcclain is a Hepatologist in Louisville, Kentucky. Dr. Mcclain is rated as a Distinguished provider by MediFind in the treatment of Primary Biliary Cholangitis. His top areas of expertise are Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcoholic Cirrhosis, Colonoscopy, and Endoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cave's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 15 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile